Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. - Wikidata - awgldk - TriplyDB

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

http://www.wikidata.org/entity/Q34502795

about

2-methoxyestradiol induces vasodilation by stimulating NO release via PPARγ/PI3K/Akt pathway.Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases.Serum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample.2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor.Cardioprotective role of G-Protein Coupled Estrogen Receptor 1 (GPER1).Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice.MicroRNA-210 suppresses glucocorticoid receptor expression in response to hypoxia in fetal rat cardiomyocytes.2-Methoxyestradiol prevents monocyte adhesion to vascular endothelial cells via downregulation of VCAM-1 expression.

P2860

Q35154584-68316AD6-F972-4AC3-A2AA-EC117CD3B74C Q35878038-08620871-E1E9-45AB-8DBE-F19D4EDBFA2F Q36751816-C3DC48F5-C88E-4956-9465-B84121AC53C5 Q36880574-9F909301-901A-494D-ACBF-341D534F5649 Q37057231-84796656-C4BC-4F32-A67C-5DA50EBB811B Q37442901-E94B0353-601A-49A8-807A-9CB7C555966C Q37624176-E97A8C0A-2637-4C95-BF9F-C963E711460E Q38448584-08210A73-4A32-4A19-A13E-2A4AABF69AAD Q41367261-9D12769E-A145-4B0F-9B41-D66896E10704 Q47147084-D80B4190-B4A1-462E-ACD4-0401208A372F Q53176139-56B3F6E8-FA55-4CB0-B169-239147BF9DED

P2860

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

http://www.wikidata.org/entity/Q34502795

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@ast

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@en

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@nl

type

label

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@ast

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@en

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@nl

prefLabel

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@ast

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@en

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@nl

P1433

Q34502795-ECD7C117-ED34-418B-B0C1-33FF26600346

P1476

Q34502795-F4BA328D-0219-4C8E-A39B-66CDF81E6351

P2093

Q34502795-08D8E958-B5CA-40FF-A4DC-744655A92E18

Q34502795-24951687-528D-47C6-A7DF-D4D63C9A1502

Q34502795-77DD5A8B-BFBF-4829-B166-F8950C1DB3FB

Q34502795-95B5C0D4-F185-4CE8-93C5-250EFAD3036A

Q34502795-973DAEBC-6D5C-4C03-97F7-6571F52A2892

Q34502795-B000BFBC-5E5F-4CD6-AFA1-B06D178A415C

Q34502795-C561B5C5-6D94-4468-BBC9-C23AB12CD3CE

Q34502795-CA611858-1B7F-493D-A732-E4DED7BD515F

Q34502795-D86FB602-4F7D-4EE9-BCEB-D4D29F22F515

Q34502795-EF02006E-07D4-45D8-B8A4-59B4460B074F

P2860

Q34502795-128CA7FC-22D4-41CC-ACBB-9B1C22BCA894

Q34502795-144FA967-E254-4B3C-8CC1-69947421C5B2

Q34502795-2B31F208-EF55-4123-AE34-AA93E2D602A8

Q34502795-37461DDF-B0FB-425F-A270-39DD549B2E26

Q34502795-44777DB0-3560-49DE-821D-25D5863931A1

Q34502795-4FA407EE-32DF-4408-A9CC-0D301A678FC5

Q34502795-5014A4AE-0BDB-469E-AC3B-5119EF24B031

Q34502795-57CABA80-3190-48D3-AAB1-EE90397F8DEA

Q34502795-5A38B910-6E68-461A-9A69-C6B38594CFF6

Q34502795-742C4B70-C059-42F6-B15F-E02251148DD0

P304

Q34502795-2EB0F1A5-99EE-4F93-95D3-0EC70B02DC96

P31

Q34502795-13F4C1E0-5B9F-4D21-98E9-8062C85BFFEA

P356

Q34502795-9037001C-B409-40A9-9230-75A2444E4FFA

P407

Q34502795-465B011E-7F9A-4D5C-BF16-FA1064A6CE26

P433

Q34502795-60EBD95A-388E-447E-8C0E-F6B61321C633

P478

Q34502795-5362CB9D-8135-431D-B166-517DF84AF1A2

P577

Q34502795-2CC98352-97BA-460E-A02F-0E22C4FFDFDD

P5875

Q34502795-92AD14FE-247E-4BE6-AE5E-79F0B6E2F91D

P698

Q34502795-350EBE1C-9C64-4E72-895C-5C91FEBD36FA

P932

Q34502795-0E251361-03DC-4449-9E52-F7E1BF9B3777

P356

HYPERTENSIONAHA.110.152298

P1433

P1476

Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

@en

P2093

Delbert G Gillespie

http://www.w3.org/2001/XMLSchema#string

Edwin K Jackson

http://www.w3.org/2001/XMLSchema#string

Eliana Lucchinetti

http://www.w3.org/2001/XMLSchema#string

Federica Barchiesi

http://www.w3.org/2001/XMLSchema#string

Marinella Rosselli

http://www.w3.org/2001/XMLSchema#string

Markus Meyer

http://www.w3.org/2001/XMLSchema#string

Matthew Wright

http://www.w3.org/2001/XMLSchema#string

Michael Zaugg

http://www.w3.org/2001/XMLSchema#string

Omolara O Ogunshola

http://www.w3.org/2001/XMLSchema#string

Raghvendra K Dubey

http://www.w3.org/2001/XMLSchema#string

P2860

Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms

Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts

2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats.

Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms.

Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents.

Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity.

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.

Cardiovascular protective effects of 17beta-estradiol metabolites.

Pathophysiology of coronary artery disease.

P304

964-972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.110.152298

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47336633

http://www.w3.org/2001/XMLSchema#string

P698

20921434

http://www.w3.org/2001/XMLSchema#string

P932

3023414

http://www.w3.org/2001/XMLSchema#string